New Zealand: Pacific Edge raises NZ$20m

New Zealand-based cancer diagnostics company Pacific Edge (PEB) has raised NZ$20m (US$13.2m) via an up-front placement and a 1-for-4.25 pro-rata renounceable rights offer. Proceeds will be used to help the company to progress its commercial objectives and, it said, to become cash-flow positive as soon as possible. “The board’s focus remains on cash and cash…

You must be a HMI Subscriber to view this content.

Subscribe Now »